MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 57 filers reported holding MEREO BIOPHARMA GROUP PLC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,100 | -2.3% | 58,217 | 0.0% | 0.00% | – |
| Q2 2023 | $76,846 | +87.8% | 58,217 | 0.0% | 0.00% | – |
| Q1 2023 | $40,921 | -5.0% | 58,217 | 0.0% | 0.00% | – |
| Q4 2022 | $43,070 | -17.2% | 58,217 | 0.0% | 0.00% | – |
| Q3 2022 | $52,000 | -27.8% | 58,217 | 0.0% | 0.00% | – |
| Q2 2022 | $72,000 | +10.8% | 58,217 | 0.0% | 0.00% | – |
| Q1 2022 | $65,000 | -31.6% | 58,217 | 0.0% | 0.00% | – |
| Q4 2021 | $95,000 | -30.7% | 58,217 | 0.0% | 0.00% | – |
| Q3 2021 | $137,000 | -23.9% | 58,217 | 0.0% | 0.00% | – |
| Q2 2021 | $180,000 | -8.2% | 58,217 | 0.0% | 0.00% | – |
| Q1 2021 | $196,000 | -7.1% | 58,217 | 0.0% | 0.00% | – |
| Q4 2020 | $211,000 | – | 58,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,854,278 | $6,638,000 | 3.61% |
| Asymmetry Capital Management, L.P. | 739,812 | $2,649,000 | 1.21% |
| Affinity Asset Advisors, LLC | 625,000 | $2,238,000 | 1.19% |
| Tri Locum Partners LP | 728,710 | $2,609,000 | 0.95% |
| Boxer Capital, LLC | 6,226,673 | $22,291,000 | 0.72% |
| DAFNA Capital Management LLC | 668,148 | $2,392,000 | 0.71% |
| Vivo Capital, LLC | 4,220,938 | $15,111,000 | 0.67% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $919,000 | 0.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 280,000 | $1,002,000 | 0.58% |
| Rubric Capital Management LP | 1,853,417 | $6,635,000 | 0.49% |